7 November 2025
At the meeting of 7 October 2025 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| fibromuscular dysplasia | 81/2025 | 82/2025 |
| cardiac myxoma | 83/2025 | 84/2025 |
| alcohol use disorder | 85/2025 | 86/2025 |
| Parkinson disease and Secondary Parkinsonism | 87/2025 | 88/2025 |
| incisional hernia | 89/2025 | 90/2025 |
| umbilical hernia, peri-umbilical hernia and para-umbilical hernia | 91/2025 | 92/2025 |
| Barrett oesophagus | 93/2025 | 94/2025 |
| optochiasmatic arachnoiditis | 95/2025 | 96/2025 |
These SOPs revoke the SOPs previously determined for these conditions.
The above SOPs take effect from 24 November 2025.
Completed Investigations
The above determinations conclude the previously advertised investigations into:
New Investigations
Decided to advertise the following investigations:
- signal to noise ratio hearing loss
- chronic multisymptom illness (Focused - Gulf War Illnes and Gulf War Syndrome)
- tension-type headache
- herpes simplex
- electrical injury
- Cushing syndrome
- central serous chorioretinopathy
- temporomandibular disorder
- mesenteric panniculitis
- bipolar disorder
- panic disorder
- cluster headache
- macular degeneration
- localised sclerosis
- olecranon bursitis
- knee bursitis
- adrenal insufficiency
- sinusitis
- reactive arthritis
- scrub typhus
- bronchiolitis obliterans organising pneumonia
The above investigation notices appear in the Government Notices Gazette of 22 October 2025.